Biolinerx Stock Investor Sentiment
| BLRX Stock | USD 4.25 0.26 5.76% |
Slightly above 54% of BioLineRx's investor base is interested to short. The analysis of the overall investor sentiment regarding BioLineRx suggests that many traders are impartial. BioLineRx's investing sentiment can be driven by a variety of factors including economic data, BioLineRx's earnings reports, geopolitical events, and overall market trends.
Comfort Level 46
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use BioLineRx's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward BioLineRx.
News SentimentBullish | Hype SentimentBearish | Insider SentimentWaiting |
BioLineRx Historical Sentiment
Although BioLineRx's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding BioLineRx, such as negative comments on social media and news outlets, may cause fear in the market and push BioLineRx's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of BioLineRx.
BioLineRx | Build AI portfolio with BioLineRx Stock |
BioLineRx Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards BioLineRx can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of BioLineRx's Stock prices. Below is the latest headlines and news related to BioLineRx Stock. The global stock market is bearish. About 68% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about BioLineRx that are available to investors today. This information is accessible both publicly - through BioLineRx's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of BioLineRx-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of BioLineRx news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BioLineRx relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BioLineRx's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BioLineRx alpha.
BioLineRx Largest EPS Surprises
Earnings surprises can significantly impact BioLineRx's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-05-25 | 2023-03-31 | -0.17 | -0.15 | 0.02 | 11 | ||
2024-11-04 | 2024-09-30 | -0.1 | -0.0728 | 0.0272 | 27 | ||
2022-09-30 | 2022-06-30 | -0.11 | -0.15 | -0.04 | 36 | ||
2022-03-16 | 2021-12-31 | -0.14 | -0.1 | 0.04 | 28 | ||
2020-11-23 | 2020-09-30 | -0.35 | -0.3 | 0.05 | 14 | ||
2019-11-19 | 2019-09-30 | -0.5 | -0.45 | 0.05 | 10 |
There is far too much social signal, news, headlines, and media speculation about BioLineRx that are available to investors today. This information is accessible both publicly - through BioLineRx's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of BioLineRx-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of BioLineRx news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BioLineRx relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BioLineRx's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BioLineRx alpha.
BioLineRx Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | BioLineRx GAAP EPS of 0.00 beats by 0.95, revenue of 0.26M misses by 1.22M | 05/27/2025 |
2 | BioLineRx Receives Buy Rating from HC Wainwright | 05/28/2025 |
3 | Dow Edges Higher Dell Shares Fall After Q1 Results | 05/30/2025 |
4 | 3 Stocks Getting Rare Double Upgrades From Analysts - The Globe and Mail | 06/06/2025 |
5 | Where BioLine Rx Stands With Analysts | 06/17/2025 |
6 | H.C. Wainwright Reaffirms Buy on BioLineRx Ltd. After ASCO 2025 | 07/03/2025 |
7 | Why Investors Shouldnt Be Surprised By BioLineRx Ltd.s 29 percent Share Price Plunge - simplywall.st | 07/08/2025 |
8 | BioLineRx Ltd. Depositary Receipt Stock Analysis and Forecast - Lightning-fast growth - Autocar Professional | 07/25/2025 |
Additional Tools for BioLineRx Stock Analysis
When running BioLineRx's price analysis, check to measure BioLineRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLineRx is operating at the current time. Most of BioLineRx's value examination focuses on studying past and present price action to predict the probability of BioLineRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLineRx's price. Additionally, you may evaluate how the addition of BioLineRx to your portfolios can decrease your overall portfolio volatility.